Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapy such as lenalidomide use different ways to stimulate the immune
system and stop tumor cells from growing. It may also stop the growth of tumor cells by
stopping blood flow to the tumor.
PURPOSE: This phase II trial is studying how well lenalidomide works in treating patients
with advanced or unresectable kidney cancer.